Qure.ai is the latest technology partner to join Medtronic's initiative in advancing stroke care management in India.
According to a press statement, their partnership aims to provide AI solutions to comprehensive stroke centres and primary stroke centres. They also seek to establish a hub-and-spoke network that will assist in faster identification, decision-making, and triaging of stroke...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
Taiwan clears VUNO's AI fundus analysis tool
South Korean firm VUNO has gained the approval of Taiwan's Food and Drug Administration to market its AI fundus analysis software.
VUNO Med-Fundus AI analyses images of the fundus to quickly detect locations of lesions indicative of retinal diseases, including diabetic retinopathy, macular disease and glaucoma.
This latest certification follows Taiwan...
Pediatric behavioral health company Brightline raised a whopping $105 million, pushing its valuation to $705 million, according to reporting by Bloomberg.
The round was led by KKR & Co., with participation from existing investors, including GV, Optum Ventures, Oak HC/FT Partners Threshold Ventures and Blue Cross Blue Shield of Massachusetts. CEO Naomi Allen told Bloomberg it would use the...
Qure.ai scores £3.2M for AI-aided cancer detection
Artificial intelligence (AI) provider Qure.ai has secured £3.2 million from SBRI Healthcare, in partnership with the NHS cancer programme and NHS Accelerated Access Collaborative.
The funding will be used to demonstrate real-world evidence of AI-aided lung cancer diagnosis, using the firm’s qXR chest X-ray interpretation technology.
Prof David...
Qure.ai scored FDA 510(k) clearance for its artificial intelligence algorithm that assists providers in placing breathing tubes.
The clearance, which officially came down in late December, is the company's third 510(k). The two previous FDA green lights were regarding its brain CT scan product.
Using chest x-rays, the qXR-BT algorithm can analyze the position of the breathing tube. It automates...
Artificial intelligence startup Fractal announced on Wednesday that it had raised $360 million from private equity firm TPG.
Srikanth Velamakanni, cofounder and group chief executive at Fractal, told TechCrunch the investment will earn the company unicorn status, reaching a valuation “at well north of $1 billion.”
Fractal, which is the parent company of healthcare AI company Qure.ai, will receive...
Indian startup Qure.ai has launched a new stroke management platform that enables remote diagnosis and decision making.
Launched in early November, the system has been rolled out in The Baptist Christian Hospital, teleradiology chain Aarthi Scans and the Kerala Institute of Medical Sciences, among others.
WHAT IT'S ABOUT
The Qure.ai Stroke Management Platform is powered by the startup's AI...
111 to build a disease management platform with Bayer
Chinese healthcare platform 111 has expanded its existing partnership with global drug maker Bayer Healthcare Co.
The two companies first entered into a strategic partnership last year in September to market innovative drugs and healthcare products for chronic disease management. A digital platform was also built to provide online pharmacist...
Global biopharmaceutical company, AstraZeneca has announced a partnership through its Emerging Markets Health Innovation Hubs programme, with India-based AI solution provider, Qure.ai.
The partnership aims to to integrate AI solutions for the early detection of lung cancer in patients across AstraZeneca’s Emerging Markets regions, covering Latin America, Asia and the Middle East & Africa.
WHY...